Get In Touch

Benzodiazepine Drugs Market - Snapshot

Benzodiazepines is a class of psychoactive drugs that are used to treat anxiety, insomnia, panic disorder, seizures, and alcohol withdrawal. These drug produce a calming effect by enhancing the effect of the neurotransmitter GABA. Benzodiazepines are widely prescribed drugs across the world. They are helpful to reduce anxiety, seizures, relax muscles, inducing sleep, and used for sedation purposes prior to surgery or general anesthesia. The global benzodiazepine drugs market was valued at around US $ 2,055 Mn in 2017. It is expected to expand at a CAGR of 2.7% from 2018 to 2026. The Alprazolam segment dominates the global market in terms of value. The market for benzodiazepine drugs is expanding significantly due to the rise in prevalence of anxiety, seizures, insomnia, and increase in concern among people about preventive measures regarding stress-related conditions. Increased adoption of generic drugs and comparatively higher prescriptions for benzodiazepines, as compared to other psychoactive drugs, also drive the market.

benzodiazepine drugs market

The benzodiazepine drugs market has been segmented based on product, application, time of action, distribution channel, and region. Based on product, the global market has been divided into Alprazolam, Clonazepam, Diazepam, Lorazepam, and others. The Alprazolam segment dominated the global market in 2017. It is projected to expand at a higher CAGR due to more number of prescriptions and wide applications in anxiety and seizures. Based on application, the global benzodiazepine drugs market has been classified into anxiety, insomnia, alcohol withdrawal, seizures, and others. Anxiety was the dominant segment of the market in 2017. It is expected to expand at a higher CAGR, owing to the rise in prevalence of anxiety and panic disorders and the better calming effect produced by benzodiazepines. In terms of time of action, the global benzodiazepine drugs market has been classified into ultra-short acting, short acting, and long acting. The short acting segment dominated the market in 2017. It is expected to maintain its position due to less hangover effect and faster onset of action. Based on distribution channel, the global benzodiazepine drugs market has been segregated into hospital pharmacies, retail pharmacies, and others. The others segment, which comprises online pharmacies and mail pharmacies, is projected to expand at a significantly higher CAGR during the forecast period. This expanded CAGR is attributed to discounted prices and convenience of usage.

 In terms of region, the global benzodiazepine drugs market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global benzodiazepine drugs market in 2017, owing to the rise in prevalence of anxiety and related conditions and higher FDA approvals of benzodiazepine drugs by major players in the region. Asia Pacific and Latin America are potential markets for benzodiazepine drugs due to increased awareness of people toward healthcare, stress conditions, and surge in healthcare expenditure.

Key players operating in the global benzodiazepine drugs market include Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma.

Increasing Prevalence of Anxiety and Insomnia Disorders Draws Demand in Benzodiazepines Drugs Market

Global benzodiazepines drugs market is on a steady rise owing to the rising prevalence of anxiety disorders and increased levels of stress in global population. Stressful and fast paced lifestyles along with unhealthy work life balance are some of the contributory factors that precede mental health disturbances. Rising number of millennial population is prone to depression and comorbid anxiety disorders. According to a report issued by the World Health Organization (WHO) in 2015, the estimated number of people suffering from anxiety disorders around the world was 264 million at the time. Unhealthy social comparisons enabled by extended usage of social networking platforms among teenagers and millennials is one of the factors contributing to this growth in mental health disorders. Growing global geriatric population and high prevalence of insomnia or other sleep disorders are some of the key motivators for global benzodiazepines drugs market.

Products in global benzodiazepines drugs market are used for sedation, sleep inducing, and reducing anxiety. They can be both, short acting or long acting, depending on the type of product. Short acting drugs have greater risk of patient suffering from withdrawal symptoms. However, they work really well in the treatment of panic disorders. Long acting drugs in benzodiazepines drugs market have longer half-life, so the drug remains in the system for a longer time, working slowly. Withdrawal symptoms for long acting drugs are not as intense as the short acting ones, as they give the patient a prolonged period of time to adjust to the drug leaving the system. Use of products in benzodiazepines drug market assists countless people to manage their anxiety and lead a normal and safe life. However, benzodiazepine drugs can be abused as it induces sleep and causes sedation. Instances of benzodiazepine overdose can lead to the death of the consumer. These factors may hinder the growth in benzodiazepines drugs market.

Benzodiazepine Drugs Market - Overview

Benzodiazepine are psychoactive drugs that are used to treat anxiety, insomnia, seizures, and alcohol withdrawal. The number of people affected with these diseases is increasing across the world. Factors such as exposure to stressful lifestyle, daily habits, and rise in geriatric population are major reasons for mental disturbance, which creates anxiety, maniac, and panic disorder conditions. People, presently, are more inclined toward prevention of these diseases. People seek relief and a calming effect to counter these conditions or symptoms. Benzodiazepine are considered to be highly effective drugs to control and calm these effects. These drugs are extensively prescribed across the world. The market for benzodiazepine drugs is expanding significantly due to an increase in prevalence of anxiety, seizures, insomnia, and rise in concern for prevention of stress and related conditions. Moreover, a comparatively higher number of prescriptions of benzodiazepine, as compared to other psychoactive drugs, and an increase in the rate of adoption of generic drugs have fuelled the benzodiazepine drugs market. The Alprazolam segment is anticipated to expand at a higher CAGR due to its wide application in anxiety, panic disorders, and higher number of prescriptions for the same.

 The benzodiazepine drugs market has been segmented based on product, application, time of action, distribution channel, and region. Based on product, the global market has been divided into Alprazolam, Clonazepam, Diazepam, Lorazepam, and others. In terms of application, the global benzodiazepine drugs market has been classified into anxiety, insomnia, alcohol withdrawal, seizures, and others. Based on time of action, the global market has been segregated into ultra-short acting, short acting, and long acting. In terms of distribution channel, the global benzodiazepine drugs market has been split into hospital pharmacies, retail pharmacies and others. Each of the segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities and useful insights. The report gives current and future market size for each segment and sub segments for the period from 2018 to 2026 in terms of value in US$ Mn, considering 2017 as the base year. The compound annual growth rate (%CAGR) has been provided for each segment and market for the period of 2018 to 2026 with market size estimations.

In terms of region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The regions have been further sub-segmented into major countries and sub-regions. The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2016 to 2026, with their growth rate (%) for the period from 2018 to 2026. The study also offers a list of recommendations, highlights and some useful insights of the market that would surely help new companies willing to enter the market and for existing companies to increase market shares, which in turn is likely to help in the decision-making process.

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, opportunities and key trends that influence the current and future status of the benzodiazepine drugs market. The report also covers market value projections, market attractiveness analysis, and key market share analysis in the market overview section in order to provide a thorough analysis of the overall competitive scenario of the global benzodiazepine drugs market.

The report concludes with the company profiles section that includes key information about the major players in the market. Key players identified in this report are Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma. Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, Business segments and recent developments.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The benzodiazepine drugs market has been segmented as follows:

Product

  • Alprazolam
  • Clonazepam
  • Diazepam
  • Lorazepam
  • Others (Clobazam, Temazepam, Midazolam, Chlordiazepoxide, Clorazepate, Estazolam, Flurazepam, Oxazepam, Triazolam, and Quazepam)

Application

  • Anxiety
  • Insomnia
  • Alcohol Withdrawal
  • Seizures
  • Others (Muscle spasm, panic disorders, general anesthesia, depression, Lennox-Gastaut syndrome, and maniac conditions)

Time of Action

  • Ultra-short Acting
  • Short Acting
  • Long Acting

Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others (Online Pharmacies, Mail Pharmacies, and Home Care Pharmacies)

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Benzodiazepine Drugs Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Benzodiazepine Drugs Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Regulatory Scenario by Region/globally
     5.2. Pipeline Analysis
     5.3. Overview of Growing Benzodiazepine Drug Misuse

6. Global Benzodiazepine Drugs Market Analysis and Forecast, by Product 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            6.3.1. Alprazolam
            6.3.2. Clonazepam
            6.3.3. Diazepam
            6.3.4. Lorazepam
            6.3.5. Others
     6.4. Global Benzodiazepine Drugs Market Attractiveness, by Product

7. Global Benzodiazepine Drugs Market Analysis and Forecast, by Application
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            7.3.1. Anxiety
            7.3.2. Insomnia
            7.3.3. Alcohol Withdrawal
            7.3.4. Seizures
            7.3.5. Others
     7.4. Global Benzodiazepine Drugs Market Attractiveness, by Application

8. Global Benzodiazepine Drugs Market Analysis and Forecast, by Time of Action
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            8.3.1. Ultra-short Acting
            8.3.2. Short Acting
            8.3.3. Long Acting
     8.4. Global Benzodiazepine Drugs Market Attractiveness, by Time of Action

9. Global Benzodiazepine Drugs Market Analysis and Forecast, by Distribution Channel
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Global Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            9.3.1. Hospital Pharmacies
            9.3.2. Retail Pharmacies
            9.3.3. Others
     9.4. Global Benzodiazepine Drugs Market Attractiveness, by Distribution Channel

10. Global Benzodiazepine Drugs Market Analysis and Forecast, by Region
     10.1. Key Findings
     10.2. Global Benzodiazepine Drugs Market Value Forecast, by Region
            10.2.1. North America 
            10.2.2. Europe 
            10.2.3. Asia Pacific 
            10.2.4. Latin America 
            10.2.5. Middle East and Africa 
     10.3. Global Benzodiazepine Drugs Market Attractiveness, by Region

11. North America Benzodiazepine Drugs Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. North America Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            11.2.1. Alprazolam
            11.2.2. Clonazepam
            11.2.3. Diazepam
            11.2.4. Lorazepam
            11.2.5. Others
     11.3. North America Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            11.3.1. Anxiety
            11.3.2. Insomnia
            11.3.3. Alcohol Withdrawal
            11.3.4. Seizures
            11.3.5. Others
     11.4. North America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
                   11.4.1. Ultra-short Acting
            11.4.2. Short Acting
            11.4.3. Long Acting
     11.5. North America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            11.5.1. Hospital Pharmacies
            11.5.2. Retail Pharmacies
            11.5.3. Others
     11.6. North America Benzodiazepine Drugs Market Value Forecast, by Country, 2016–2026
            11.6.1. U.S.
            11.6.2. Canada
     11.7. North America Benzodiazepine Drugs Market Attractiveness Analysis 
            11.7.1. By Product 
            11.7.2. By Application 
            11.7.3. By Time of Action
            11.7.4. By Distribution Channel
            11.7.5. By Country

12. Europe Benzodiazepine Drugs Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Europe Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            12.2.1. Alprazolam
            12.2.2. Clonazepam
            12.2.3. Diazepam
            12.2.4. Lorazepam
            12.2.5. Others
     12.3. Europe Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            12.3.1. Anxiety
            12.3.2. Insomnia
            12.3.3. Alcohol Withdrawal
            12.3.4. Seizures
            12.3.5. Others
     12.4. Europe Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            12.4.1. Ultra-short Acting
            12.4.2. Short Acting
            12.4.3. Long Acting
     12.5. Europe Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            12.5.1. Hospital Pharmacies
            12.5.2. Retail Pharmacies
            12.5.3. Others
     12.6. Europe Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            12.6.1. Germany
            12.6.2. U.K.
            12.6.3. France
            12.6.4. Italy
            12.6.5. Spain
            12.6.6. Rest of Europe 
     12.7. Europe Benzodiazepine Drugs Market Attractiveness Analysis 
            12.7.1. By Product 
            12.7.2. By Application 
            12.7.3. By Time of Action
            12.7.4. By Distribution Channel
            12.7.5. By Country/Sub-region

13. Asia Pacific Benzodiazepine Drugs Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            13.2.1. Alprazolam
            13.2.2. Clonazepam
            13.2.3. Diazepam
            13.2.4. Lorazepam
            13.2.5. Others
     13.3. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            13.3.1. Anxiety
            13.3.2. Insomnia
            13.3.3. Alcohol Withdrawal
            13.3.4. Seizures
            13.3.5. Others
     13.4. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            13.4.1. Ultra-short Acting
            13.4.2. Short Acting
            13.4.3. Long Acting
     13.5. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            13.5.1. Hospital Pharmacies
            13.5.2. Retail Pharmacies
            13.5.3. Others
     13.6. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            13.6.1. China
            13.6.2. India
            13.6.3. Japan
            13.6.4. Australia & New Zealand
            13.6.5. Rest of APAC
     13.7. Asia Pacific Benzodiazepine Drugs Market Attractiveness Analysis 
            13.7.1. By Product 
            13.7.2. By Application 
            13.7.3. By Time of Action
            13.7.4. By Distribution Channel
            13.7.5. By Country/Sub-region

14. Latin America Benzodiazepine Drugs Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Latin America Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            14.2.1. Alprazolam
            14.2.2. Clonazepam
            14.2.3. Diazepam
            14.2.4. Lorazepam
            14.2.5. Others
     14.3. Latin America Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            14.3.1. Anxiety
            14.3.2. Insomnia
            14.3.3. Alcohol Withdrawal
            14.3.4. Seizures
            14.3.5. Others
     14.4. Latin America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            14.4.1. Ultra-short Acting
            14.4.2. Short Acting
            14.4.3. Long Acting
     14.5. Latin America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            14.5.1. Hospital Pharmacies
            14.5.2. Retail Pharmacies
            14.5.3. Others
     14.6. Latin America Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            14.6.1. Brazil
            14.6.2.Mexico
            14.6.3. Rest of LATAM 
     14.7. Latin America Benzodiazepine Drugs Market Attractiveness Analysis 
            14.7.1. By Product 
            14.7.2. By Application 
            14.7.3. By Time of Action
            14.7.4. By Distribution Channel
            14.7.5. By Country/Sub-region

15. Middle East & Africa Benzodiazepine Drugs Market Analysis and Forecast
     15.1. Introduction
            15.1.1. Key Findings
     15.2. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            15.2.1. Alprazolam
            15.2.2. Clonazepam
            15.2.3. Diazepam
            15.2.4. Lorazepam
            15.2.5. Others
     15.3. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            15.3.1. Anxiety
            15.3.2. Insomnia
            15.3.3. Alcohol Withdrawal
            15.3.4. Seizures
            15.3.5. Others
     15.4. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            15.4.1. Ultra-short Acting
            15.4.2. Short Acting
            15.4.3. Long Acting
     15.5. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            15.5.1. Hospital Pharmacies
            15.5.2. Retail Pharmacies
            15.5.3. Others
     15.6. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            15.6.1. GCC Countries
            15.6.2.South Africa
            15.6.3. Rest of MEA
     15.7. Middle East & Africa Benzodiazepine Drugs Market Attractiveness Analysis 
            15.7.1. By Product 
            15.7.2. By Application 
            15.7.3. By Time of Action
            15.7.4. By Distribution Channel
            15.7.5. By Country/Sub-region

16. Competition Landscape
     16.1.Market Player – Competition Matrix (By Tier and Size of companies)
     16.2.Market Share Analysis By Tier and Size of the Company (2017)
     16.3. Company Profiles
            16.3.1. Pfizer Inc.
            16.3.2. F.Hoffmann-La Roche Ltd.
            16.3.3. Bausch Health Companies, Inc.
            16.3.4. Mylan N.V. 
            16.3.5. Teva Pharmaceutical Industries Ltd. 
            16.3.6. H.Lundbeck A/S 
            16.3.7. Amneal Pharmaceuticals LLC 
            16.3.8. Sun Pharmaceutical Industries Ltd.
            16.3.9. Apotex Inc. 
            16.3.10. Aurobindo Pharma

List of Tables

Table 01: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 04: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 05: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 08: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 09: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 10: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 11: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 14: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 15: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 17: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 18: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 19: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 20: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 21: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 25: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 26: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 28: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 29: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 30: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

List of Figures

Figure 01: Global Benzodiazepine Drugs Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Product
Figure 03: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Application
Figure 04: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Time of Action
Figure 05: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Distribution Channel
Figure 06: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, 2016–2026
Figure 07: Global Benzodiazepine Drugs Market Value Share, by Product (2017)
Figure 08: Global Benzodiazepine Drugs Market Value Share, by Application (2017)
Figure 09: Global Benzodiazepine Drugs Market Value Share, by Time of Action (2017)
Figure 10: Global Benzodiazepine Drugs Market Value Share, by Distribution Channel (2017)
Figure 11: Global Benzodiazepine Drugs Market Value Share, by Region (2017)
Figure 12: Global Benzodiazepine Drugs Market Value Share Analysis, by Product, 2017 and 2026
Figure 13: Global Alprazolam Market Value (US$) and Y-o-Y Growth (%), 2016–2026
Figure 14: Global Clonazepam Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 15: Global Diazepam Market Value (US$) and Y-o-Y Growth (%), 2016–2026
Figure 16: Global Lorazepam Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 17: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 18: Benzodiazepine Drugs Market Attractiveness Analysis, by Product
Figure 19: Global Benzodiazepine Drugs Market Value Share Analysis, by Application, 2017 and 2026
Figure 20: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Anxiety, 2016–2026
Figure 21: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Insomnia, 2016–2026
Figure 22: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Alcohol Withdrawal, 2016–2026
Figure 23: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Seizures, 2016–2026
Figure 24: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 25: Benzodiazepine Drugs Market Attractiveness Analysis, by Application 
Figure 26: Global Benzodiazepine Drugs Market Value Share Analysis, by Time of Action, 2017 and 2026
Figure 27: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ultra-short Acting, 2016–2026
Figure 28: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Short Acting, 2016–2026
Figure 29: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Long Acting, 2016–2026
Figure 30: Benzodiazepine Drugs Market Attractiveness Analysis, by Time of Action
Figure 31: Global Benzodiazepine Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 32: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2016–2026
Figure 33: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Retails Pharmacies, 2016–2026
Figure 34: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 35: Benzodiazepine Drugs Market Attractiveness Analysis, by Distribution Channel
Figure 36: Global Benzodiazepine Drugs Market Value Share, by Region, 2017 and 2026
Figure 37: Global Benzodiazepine Drugs Market Attractiveness Analysis, by Region, 2018–2026
Figure 38: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 39: North America Benzodiazepine Drugs Market Value Share, by Country, 2017 and 2026
Figure 40: North America Benzodiazepine Drugs Market Attractiveness, by Country, 2017–2026
Figure 41: North America Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 42: North America Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 43: North America Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 44: North America Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 45: North America Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 46: North America Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 47: North America Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 48: North America Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 49: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 50: Europe Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 51: Europe Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 52: Europe Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 53: Europe Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 54: Europe Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 55: Europe Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 56: Europe Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 57: Europe Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 58: Europe Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 59: Europe Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 60: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 61: Asia Pacific Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 62: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 63: Asia Pacific Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 64: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 65: Asia Pacific Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 66: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 67: Asia Pacific Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 68: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 69: Asia Pacific Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 70: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 71: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 72: Latin America Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 73: Latin America Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 74: Latin America Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 75: Latin America Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 76: Latin America Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 77: Latin America Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 78: Latin America Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 79: Latin America Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 80: Latin America Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 81: Latin America Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 82: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 83: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 84: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 85: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 86: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 87: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 88: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 89: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 90: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 91: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 92: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 93: Market Share Analysis (%), 2017, by Tier and Size of the Company

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Benzodiazepine Drugs Market